Drug Profile
Research programme: Non narcotic analgesics - Vapogenix
Latest Information Update: 28 Mar 2021
Price :
$50
*
At a glance
- Originator University of Texas M. D. Anderson Cancer Center; Vapogenix
- Class Anaesthetics; Analgesics; Anti-inflammatories; Non-opioid analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Inflammatory pain; Pain
Most Recent Events
- 28 Mar 2021 No recent reports of development identified for research development in Inflammatory-pain in USA (Topical, Gel)
- 28 Feb 2021 No recent reports of development identified for preclinical development in Pain in USA (Topical, Gel)
- 16 Feb 2017 Early research in Inflammatory pain in USA (Topical) (Texas Emerging Technology pipeline, January 2017)